AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
A SYSTEMIC BIOACTIVITY COMPARISON OF DOUBLE-STRENGTH AND REGULAR-STRENGTH BECLOMETHASONE DIPROPIONATE MDI FORMULATIONS
Authors: BRANNAN MD HERRON JM REIDENBERG P AFFRIME MB
Citation: Md. Brannan et al., A SYSTEMIC BIOACTIVITY COMPARISON OF DOUBLE-STRENGTH AND REGULAR-STRENGTH BECLOMETHASONE DIPROPIONATE MDI FORMULATIONS, Annals of allergy, asthma, & immunology, 80(1), 1998, pp. 39-44
DISPOSITION OF C-14-EPTIFIBATIDE AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-MEN
Authors: ALTON KB KOSOGLOU T BAKER S AFFRIME MB CAYEN MN PATRICK JE
Citation: Kb. Alton et al., DISPOSITION OF C-14-EPTIFIBATIDE AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-MEN, Clinical therapeutics, 20(2), 1998, pp. 307-323
SAFETY AND TOLERABILITY OF ONCE-DAILY MOMETASONE FUROATE AQUEOUS NASAL SPRAY IN PEDIATRIC-PATIENTS
Authors: BRANNAN MD HERRON JM AFFRIME MB
Citation: Md. Brannan et al., SAFETY AND TOLERABILITY OF ONCE-DAILY MOMETASONE FUROATE AQUEOUS NASAL SPRAY IN PEDIATRIC-PATIENTS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 1008-1008
DISPOSITION OF C-14-EPTIFIBATIDE AFTER IV BOLUS ADMINISTRATION IN HEALTHY-SUBJECTS
Authors: KOSOGLOU T ALTON KB BAKER S AFFRIME MB CAYEN MN PATRICK JE
Citation: T. Kosoglou et al., DISPOSITION OF C-14-EPTIFIBATIDE AFTER IV BOLUS ADMINISTRATION IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
LACK OF CORRELATION BETWEEN INTRAVENOUS MIDAZOLAM AND ORAL DEXTROMETHORPHAN CYP3A PHENOTYPES
Authors: GORSKI JC HAEHNER BD CUTLER D AFFRIME MB HALL SD
Citation: Jc. Gorski et al., LACK OF CORRELATION BETWEEN INTRAVENOUS MIDAZOLAM AND ORAL DEXTROMETHORPHAN CYP3A PHENOTYPES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 54-54
THE SELECTIVE IN-VIVO INCREASE OF CYTOCHROME-P450 2C8 9 ACTIVITY BY INTERLEUKIN-10 (IL-10)/
Authors: HAEHNERDANIELS BD CUTLER DL AFFRIME MB GORSKI JC HALL SD
Citation: Bd. Haehnerdaniels et al., THE SELECTIVE IN-VIVO INCREASE OF CYTOCHROME-P450 2C8 9 ACTIVITY BY INTERLEUKIN-10 (IL-10)/, Clinical pharmacology and therapeutics, 63(2), 1998, p.
PHARMACOKINETICS AND DYNAMICS (CYTOKINE SUPPRESSION) OF IV AND SC RECOMBINANT HUMAN INTERLEUKIN-19
Authors: RADWANSKI E CHAKRABORTY A VANWART S CUTLER DL AFFRIME MB JUSKO WJ
Citation: E. Radwanski et al., PHARMACOKINETICS AND DYNAMICS (CYTOKINE SUPPRESSION) OF IV AND SC RECOMBINANT HUMAN INTERLEUKIN-19, Clinical pharmacology and therapeutics, 63(2), 1998, p.
IL-10 INHIBITS ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING HUMAN ENDOTOXEMIA
Authors: PAJKRT D VANDERPOOL T LEVI M CUTLER DL AFFRIME MB VANDENENDER A TENCATE JW VANDEVENTER SJH
Citation: D. Pajkrt et al., IL-10 INHIBITS ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING HUMAN ENDOTOXEMIA, Thrombosis and haemostasis, 1997, pp. 2452-2452
SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF FELBAMATE IN THE ELDERLY
Authors: RICHENS A BANFIELD CR SALFI M NOMEIR A LIN CC JENSEN P AFFRIME MB GLUE P
Citation: A. Richens et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF FELBAMATE IN THE ELDERLY, British journal of clinical pharmacology, 44(2), 1997, pp. 129-134
SINGLE-DOSE PHARMACOKINETICS OF FELBAMATE IN PATIENTS WITH RENAL DYSFUNCTION
Authors: GLUE P SULOWICZ W COLUCCI R BANFIELD C PAI S LIN C AFFRIME MB
Citation: P. Glue et al., SINGLE-DOSE PHARMACOKINETICS OF FELBAMATE IN PATIENTS WITH RENAL DYSFUNCTION, British journal of clinical pharmacology, 44(1), 1997, pp. 91-93
COMPARATIVE PHARMACOKINETICS OF ORAL CEFTIBUTEN, CEFIXIME, CEFACLOR, AND CEFUROXIME AXETIL IN HEALTHY-VOLUNTEERS
Authors: NIX DE SYMONDS WT HYATT JM WILTON JH TEAL MA REIDENBERG P AFFRIME MB
Citation: De. Nix et al., COMPARATIVE PHARMACOKINETICS OF ORAL CEFTIBUTEN, CEFIXIME, CEFACLOR, AND CEFUROXIME AXETIL IN HEALTHY-VOLUNTEERS, Pharmacotherapy, 17(1), 1997, pp. 121-125
SAFETY AND TOLERABILITY OF ONCE-DAILY MOMETASONE FUROATE AQUEOUS NASAL SPRAY IN CHILDREN
Authors: BRANNAN MD HERRON JM AFFRIME MB
Citation: Md. Brannan et al., SAFETY AND TOLERABILITY OF ONCE-DAILY MOMETASONE FUROATE AQUEOUS NASAL SPRAY IN CHILDREN, Clinical therapeutics, 19(6), 1997, pp. 1330-1339
PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES
Authors: KOSOGLOU T RADWANSKI E BATRA VK LIM JM CHRISTOPHER D AFFRIME MB
Citation: T. Kosoglou et al., PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES, Clinical therapeutics, 19(5), 1997, pp. 1002-1012
ATTENUATION OF PROINFLAMMATORY RESPONSE BY RECOMBINANT HUMAN IL-10 INHUMAN ENDOTOXEMIA - EFFECT OF TIMING OF RECOMBINANT HUMAN IL-10 ADMINISTRATION
Authors: PAJKRT D CAMOGLIO L TIELVANBUUL MCM DEBRUIN K CUTLER DL AFFRIME MB RIKKEN G VANDERPOLL T TENCATE JW VANDEVENTER SJH
Citation: D. Pajkrt et al., ATTENUATION OF PROINFLAMMATORY RESPONSE BY RECOMBINANT HUMAN IL-10 INHUMAN ENDOTOXEMIA - EFFECT OF TIMING OF RECOMBINANT HUMAN IL-10 ADMINISTRATION, The Journal of immunology, 158(8), 1997, pp. 3971-3977
PHARMACODYNAMICS OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS
Authors: HUHN RD RADWANSKI E GALLO J AFFRIME MB SABO R GONYO G MONGE A CUTLER DL
Citation: Rd. Huhn et al., PHARMACODYNAMICS OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 171-180
DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION
Authors: LAMBRECHT LJ SWAN SK CUTLER DL AFFRIME MB RADWANSKI E BATRA V MACRES M
Citation: Lj. Lambrecht et al., DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 87-87
RECOMBINANT HUMAN IL-10 (RHUIL-10) INHIBITS DELAYED-TYPE HYPERSENSITIVITY RESPONSE (DTH) IN HEALTHY-VOLUNTEERS
Authors: CUTLER DL AFFRIME MB HERRON J SABO R
Citation: Dl. Cutler et al., RECOMBINANT HUMAN IL-10 (RHUIL-10) INHIBITS DELAYED-TYPE HYPERSENSITIVITY RESPONSE (DTH) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 92-92
INTERLEUKIN-10 INHIBITS ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING ENDOTOXEMIA
Authors: PAJKRT D VANDERPOLL T LEVI M CUTLER DL AFFRIME MB VANDENENDE A TENCATE JW VANDEVENTER SJH
Citation: D. Pajkrt et al., INTERLEUKIN-10 INHIBITS ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING ENDOTOXEMIA, Blood, 89(8), 1997, pp. 2701-2705
EFFECTS OF SINGLE INTRAVENOUS (IV) DOSES OF RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) ON SUBSETS OF BLOOD LEUKOCYTES IN HEALTHY-VOLUNTEERS
Authors: HUHN RD PENNLINE K SABO R CLARKE L AFFRIME MB CUTLER DL
Citation: Rd. Huhn et al., EFFECTS OF SINGLE INTRAVENOUS (IV) DOSES OF RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) ON SUBSETS OF BLOOD LEUKOCYTES IN HEALTHY-VOLUNTEERS, Journal of investigative medicine, 44(3), 1996, pp. 275-275
CLINICAL, HEMATOLOGIC, AND IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-10 INHUMANS
Authors: FUCHS AC GRANOWITZ EV SHAPIRO L VANNIER E LONNEMANN G ANGEL JB KENNEDY JS RABSON AR RADWANSKI E AFFRIME MB CUTLER DL GRINT PC DINARELLO CA
Citation: Ac. Fuchs et al., CLINICAL, HEMATOLOGIC, AND IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-10 INHUMANS, Journal of clinical immunology, 16(5), 1996, pp. 291-303
THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING
Authors: BANFIELD CR ZHU GRR JEN JF JENSEN PK SCHUMAKER RC PERHACH JL AFFRIME MB GLUE P
Citation: Cr. Banfield et al., THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING, Therapeutic drug monitoring, 18(1), 1996, pp. 19-29
LACK OF SYSTEMIC ACTIVITY WITH INTRANASAL MOMETASONE FUROATE
Authors: BRANNAN MD SEIBERLING M CUTLER DL CUSS FM AFFRIME MB
Citation: Md. Brannan et al., LACK OF SYSTEMIC ACTIVITY WITH INTRANASAL MOMETASONE FUROATE, Journal of allergy and clinical immunology, 97(1), 1996, pp. 62-62
EFFECT OF FELBAMATE ON THE PHARMACOKINETICS OF LAMOTRIGINE
Authors: COLUCCI R GLUE P HOLT B BANFIELD C REIDENBERG P MEEAHN JW PAI S NOMEIR A LIM J LIN CC AFFRIME MB
Citation: R. Colucci et al., EFFECT OF FELBAMATE ON THE PHARMACOKINETICS OF LAMOTRIGINE, Journal of clinical pharmacology, 36(7), 1996, pp. 634-638
INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS
Authors: NOMEIR AA MOJAVERIAN P KOSOGLOU T AFFRIME MB NEZAMIS J RADWANSKI E LIN CC CAYEN MN
Citation: Aa. Nomeir et al., INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(10), 1996, pp. 923-930
EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE
Authors: KOSOGLOU T MOJAVERIAN P RADWANSKI E CHRISTOPHER D CUTLER DL LIN CC AFFRIME MB
Citation: T. Kosoglou et al., EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 24-24
Risultati: 1-25 | 26-42